Key result
Two serologically different FMDV strains with identical A and C sites showed significant antigenic diversification mediated by four amino acid substitutions at three other antigenic sites.
Identity of antigenic sites A and C in FMDV may not be sufficient to induce cross-protection due to significant antigenic diversification mediated by amino acid substitutions outside these sites.
May not ensure cross-protection despite identical A/C sites; leaves open roles of other substitutions for FMDV vaccine design.
The antigenic sites A and C (the G-H loop and the C terminus, respectively) in VP1 of foot-and-mouth disease virus (FMDV) have been considered the immunodominant regions of the virus involved in the induction of protection. Other antigenic sites have been described but their involvement in protection has not been established. Here we report that two closely related but serologically different FMDVs (the field isolate C3 Argentina/84 and the vaccine strain C3 Resende Br/55) have identical A and C sites but differ as other antigenic sites. Such differences have been documented by reactivity with a panel of 28 monoclonal antibodies (MAbs). The two viruses reacted to the same extent with each of 13 MAbs which recognized epitopes within sites A or C, but reacted differently with six out of 15 MAbs that recognized other sites. Accordingly, sequencing of the entire region coding for the capsid proteins, for both viruses, revealed four amino acid substitutions at three antigenic sites other than A and C. The results suggest that identity of sites A and C may not be sufficient to induce cross-protection, and provide the first evidence of significant antigenic diversification of FMDV in the field mediated by amino acid substitutions outside sites A or C.
No takes yet. Share an insight, caveat, or question.
Feigelstock et al. (1992) studied Foot-and-mouth disease virus (FMDV). FMDV field isolate C3 Argentina/84 vs. FMDV vaccine strain C3 Resende Br/55 was evaluated on Reactivity with a panel of 28 monoclonal antibodies and amino acid substitutions. Two serologically different FMDV strains with identical A and C sites showed significant antigenic diversification mediated by four amino acid substitutions at three other antigenic sites.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: